NeoPharm CO., LTD. (KOSDAQ:092730)
19,450
-250 (-1.27%)
At close: Dec 5, 2025
NeoPharm CO., LTD. Company Description
NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand.
NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
NeoPharm CO., LTD.
| Country | South Korea |
| Founded | 2000 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 184 |
| CEO | Byeong-Deog Park |
Contact Details
Address: 309-8, Techno 2-ro Daejeon South Korea | |
| Phone | 82 4 2863 0038 |
| Website | neopharm.co.kr |
Stock Details
| Ticker Symbol | 092730 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7092730001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Byeong-Deog Park | Chief Executive Officer |